Ventricular Arrhythmia - Vietnam Registration 2402671ĐKLH/BYT-HTTB

Access comprehensive regulatory information for Ventricular Arrhythmia in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại D medical device is registered under number 2402671ĐKLH/BYT-HTTB and manufactured by Conic Vascular Technology, S.A.. The authorized representative in Vietnam is CÔNG TY TNHH DƯỢC PHẨM VÀ THIẾT BỊ Y TẾ LONG BÌNH.

This page provides complete technical specifications, regulatory compliance details, 5 companies making similar products including Boston Scientific, Abbott Medical, and 5 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database

300,000+ Devices

5 Competitors

5 Recent Registrations

2402671ĐKLH/BYT-HTTB

Registration Details

Vietnam MOH Registration: 2402671ĐKLH/BYT-HTTB

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Ventricular Arrhythmia

VN: Bóng nong động mạch vành

Risk Class TTBYT Loại D

Registration Details

Analysis ID

2402671ĐKLH/BYT-HTTB

Submission ID

000.00.04.G18-230313-0003

Product Type

Theo theo phụ lục

Product Code

Theo phụ lục

Technical Details

Intended Use

OBJECTIVE: The clinical data currently available indicate that the lumen diameter of the coronary artery at the location of certain types of stenosis can increase due to the expansion of the balloon and PTCA is a safe and effective procedure to reduce some forms of coronary artery disease caused by atherosclerosis (see Indications). INDICATIONS: PTCA (percutaneous transluminal coronary angioplasty) may be indicated by the physician for patients with severe coronary artery disease who are candidates for coronary artery bypass surgery and who meet one of the following selection criteria: 1. The patient has atherosclerotic coronary artery disease that is amenable to balloon dilation. 2. The patient has atherosclerotic disease of the native coronary arteries and/or a coronary artery bypass graft and has recurrent symptoms and (a) progressive disease or (b) narrowing and occlusion of the graft